Skip to content

Why Fusion?

Fusion biopsies performed with the Fusion Bx can reduce the chances of operator error, minimize procedure times and open the door for focal therapy.

The prostate remains the only organ where a blind sampling technique is standard practice. As a result, cancer may be missed entirely, or if detected, it is difficult to determine the extent and severity. This leads to under treatment of men with serious disease and over-treatment of men with indolent disease.


Unlike systematic biopsies, MRI-targeted biopsies are targeted and repeatable. They reduce the risk of over-diagnosis and over-treatment, while minimizing the potential for operator error.

MRI could be used as a triage test to avoid biopsy if the results are negative, whereas positive results could be used for targeting regions of interest during biopsy.

early diagnosis

Compared to ultrasound, MRI can be considered the “Gold Standard” for visualizing lesions. Using the model as a map and the projected needle path as a compass, physicians can accurately target ROIs in real time.


“Fusion Bx was easily adopted by our clinic. Now, fusion biopsies are a part of our weekly routine.”

– Dr. Winston Barzell, 21st Century Oncology, USA


fusion biopsy workflow

See how Fusion MR Viewer and the Fusion Bx 2.0 work together and integrate with third party devices to facilitate targeted procedures from diagnosis to treatment.